240-566-3300

Breast Clinical Trials

Study Name: (CAPItello-292)

Description: Capivasertib + CDK4/6i + Fulvestrant for Advanced/Metastatic HR+/HER2- Breast Cancer (CAPItello-292)
Study Number: D361DC00001
FHH or Referral: Referral
NCT#: NCT04862663
Cancer Stage: IV
Key Inclusion: HR+/HER2-

All Locations

Frederick Health Rose Hill | Chest Surgery Medical Office Building
1562 Opossumtown Pike
Frederick, MD 21702
301-694-5861
More Information
Frederick Health Rose Hill | Urology Medical Office Building
1562 Opossumtown Pike
Frederick, MD 21702
301-663-4774
More Information
James M Stockman Cancer Institute Medical Office Building
1562 Opossumtown Pike
Frederick, MD 21702
240-215-6310
More Information
James M Stockman Cancer Institute | Infusion Therapy Medical Office Building
1562 Opossumtown Pike
Frederick, MD 21702
301-694-5580
More Information
James M Stockman Cancer Institute | Integrative Services Medical Office Building
1562 Opossumtown Pike
Frederick, MD 21702
240-566-4100
More Information
James M Stockman Cancer Institute | Oncology & Hematology Medical Office Building
1562 Opossumtown Pike
Frederick, MD 21702
240-566-4100
More Information
James M Stockman Cancer Institute | Radiation Medicine Medical Office Building
1562 Opossumtown Pike
Frederick, MD 21702
240-566-4500
More Information
Supportive & Geriatric Care at Toll House Medical Office Building
501 W 7th St
Frederick, MD 21701
240-566-3031
More Information

/

View All